Literature DB >> 32285555

A framework for open tracheostomy in COVID-19 patients.

Tony Jacob1, Abigail Walker1, Angelos Mantelakis1, Nicholas Gibbins1, Oliver Keane2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32285555      PMCID: PMC7262328          DOI: 10.1111/coa.13549

Source DB:  PubMed          Journal:  Clin Otolaryngol        ISSN: 1749-4478            Impact factor:   2.597


× No keyword cloud information.
Sir The COVID‐19 pandemic is causing untold disruption across the globe, and all countries irrespective of the strength and resilience of their health systems are feeling the burden. Intensive care units are facing a surge of patients requiring invasive ventilation. It is likely that requests for a tracheostomy in COVID‐19 ventilated patients will soon come our way. It is difficult to predict the burden, but it would be remiss not to be prepared. Tracheostomy is almost certainly an aerosol generating procedure and represents a risk to surgeons and others in the operating room. In the SARS epidemic, a survey suggested that healthcare workers who performed tracheostomy had a fourfold increased risk of developing disease. Full personal protective equipment must be used, as failure to comply is a risk factor for infection in healthcare workers. , We have developed guidance and cognitive aids to help departments prepare for tracheostomies in COVID‐19 patients (Figure 1A‐D), based upon processes that we believe minimise risk of aerosol generation. This builds on earlier opinion and incorporates our experience from simulation with a multidisciplinary team. We also consulted with a number of stakeholders, the Head & Neck Society of ENT UK, British Head & Neck Oncologists (BAHNO), British Laryngological Association, National Tracheostomy Safety Project, Difficult Airway Society (DAS) and the executive of ENT UK, who endorse the guidance.
Figure 1

A, Planning steps recommended in the days and weeks prior to predicted tracheostomy. PPE = Personal Protective Equipment, COVID = novel Coronavirus‐19 (nCov19), ICU: Intensive Care Unit, B, Proposed checklist for the day of tracheostomy. HME = Heat and Moisture Exchanger, ETT: Endotracheal tube. C, Performance of critical steps in open tracheostomy once the trachea is exposed. PEEP = Positive End‐Expiratory Pressure, APL valve = Adjustable Pressure Limiting valve, CO2 = carbon dioxide, D, Care for the tracheostomy patient after procedure in critical care and beyond. SLT = Speech and Language Therapist

A, Planning steps recommended in the days and weeks prior to predicted tracheostomy. PPE = Personal Protective Equipment, COVID = novel Coronavirus‐19 (nCov19), ICU: Intensive Care Unit, B, Proposed checklist for the day of tracheostomy. HME = Heat and Moisture Exchanger, ETT: Endotracheal tube. C, Performance of critical steps in open tracheostomy once the trachea is exposed. PEEP = Positive End‐Expiratory Pressure, APL valve = Adjustable Pressure Limiting valve, CO2 = carbon dioxide, D, Care for the tracheostomy patient after procedure in critical care and beyond. SLT = Speech and Language Therapist Although general complications rates using a percutaneous technique are largely similar to open tracheostomies, the unanswered question here is which generates less aerosol exposure to the healthcare workers involved. Our own work with simulation would suggest that a controlled open technique as described here is potentially safer, but this is not yet validated in practice. This and other questions about when and where to perform these interventions will be influenced by local factors, competencies and experience. Therefore, without being prescriptive, this guide is aimed at outlining the steps that can be taken by surgeons to best protect themselves and minimise aerosol generation when called on to perform open surgical tracheostomies on COVID‐19 patients. We suggest that departments identify a core “COVID‐19 Airway team” who can rapidly adapt these guidelines to local factors and take a lead in training their colleagues. It is necessary and advisable to share the burden of these high risk and stressful events amongst all colleagues. The key message is to prepare and stay safe.

CONFLICT OF INTEREST

None declared.
  4 in total

Review 1.  Percutaneous techniques versus surgical techniques for tracheostomy.

Authors:  Patrick Brass; Martin Hellmich; Angelika Ladra; Jürgen Ladra; Anna Wrzosek
Journal:  Cochrane Database Syst Rev       Date:  2016-07-20

2.  Infection control measures for operative procedures in severe acute respiratory syndrome-related patients.

Authors:  Victor Wei Ter Chee; Mark Li-Chung Khoo; Sow Fong Lee; Yeow Choy Lai; Ngek Mien Chin
Journal:  Anesthesiology       Date:  2004-06       Impact factor: 7.892

3.  Which preventive measures might protect health care workers from SARS?

Authors:  Wei-Qing Chen; Wen-Hua Ling; Ci-Yong Lu; Yuan-Tao Hao; Zhong-Ning Lin; Li Ling; Jian Huang; Gang Li; Guang-Mei Yan
Journal:  BMC Public Health       Date:  2009-03-13       Impact factor: 3.295

4.  Severe acute respiratory syndrome (SARS) in intensive care units (ICUs): limiting the risk to healthcare workers.

Authors:  J W Tang; R C W Chan
Journal:  Curr Anaesth Crit Care       Date:  2004-06-26
  4 in total
  13 in total

1.  Per-cutaneous dilatation tracheostomy (PCTD) in COVID-19 patients and peri-tracheostomy care: A case series and guidelines.

Authors:  Ehtesham Khan; Shankar Lal; Junaid Hashmi; Jubil Thomas; Muhammad Anwar Malik
Journal:  Pak J Med Sci       Date:  2020 Nov-Dec       Impact factor: 1.088

Review 2.  Terapia de voz en el contexto de la pandemia covid-19; recomendaciones para la práctica clínica.

Authors:  Adrián Castillo-Allendes; Francisco Contreras-Ruston; Lady Cantor; Juliana Codino; Marco Guzman; Celina Malebran; Carlos Manzano; Axel Pavez; Thays Vaiano; Fabiana Wilder; Mara Behlau
Journal:  J Voice       Date:  2020-08-22       Impact factor: 2.009

Review 3.  Terapia Vocal No Contexto Da Pandemia Do Covid-19; Orientações Para A Prática Clínica.

Authors:  Adrián Castillo-Allendes; Francisco Contreras-Ruston; Lady Cantor; Juliana Codino; Marco Guzman; Celina Malebran; Carlos Manzano; Axel Pavez; Thays Vaiano; Fabiana Wilder; Mara Behlau
Journal:  J Voice       Date:  2020-08-20       Impact factor: 2.009

4.  Practical considerations for the operative team in performing tracheostomy during the COVID-19 pandemic.

Authors:  Ming Yann Lim; Yijin Jereme Gan; Bin Hui Tan; Kim Meng Kwan; Quan Qing Richmond Lim; Sow Fong Lee; Yaw Khian Chong
Journal:  Singapore Med J       Date:  2020-06-26       Impact factor: 1.858

5.  Recommendations for head and neck surgical procedures during the COVID-19 pandemic.

Authors:  Marco A V Kulcsar; Fabio L M Montenegro; André B O Santos; Marcos R Tavares; Sergio S Arap; Luiz P Kowalski
Journal:  Clinics (Sao Paulo)       Date:  2020-07-06       Impact factor: 2.365

Review 6.  COVID-19: What are the challenges for NHS surgery?

Authors:  Natasha L Wielogórska; Chidi C Ekwobi
Journal:  Curr Probl Surg       Date:  2020-07-02       Impact factor: 1.909

Review 7.  Protection for Otolaryngologic Surgery in the COVID-19 Pandemic.

Authors:  Antonia E Lagos; Phoebe H Ramos; Tomás Andrade
Journal:  OTO Open       Date:  2020-06-08

Review 8.  Voice Therapy in the Context of the COVID-19 Pandemic: Guidelines for Clinical Practice.

Authors:  Adrián Castillo-Allendes; Francisco Contreras-Ruston; Lady Catherine Cantor-Cutiva; Juliana Codino; Marco Guzman; Celina Malebran; Carlos Manzano; Axel Pavez; Thays Vaiano; Fabiana Wilder; Mara Behlau
Journal:  J Voice       Date:  2020-08-07       Impact factor: 2.009

9.  A Systematic Review on Tracheostomy in COVID-19 Patients: Current Guidelines and Safety Measures.

Authors:  Amitabha Mandal; Sourabh Nandi; Madiwalesh Chhebbi; Abhijit Basu; Mukurdipi Ray
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2020-09-28

Review 10.  Overview of Upper Airway Management During COVID-19 Outbreak: Head and Neck Surgeon's Perspective.

Authors:  Ahmad Al Omari; Ra'ed Al-Ashqar; Amjad Nuseir; Hassan Al Balas; Hadeel Allan; Yazan Kanaan; Firas Alzoubi
Journal:  J Craniofac Surg       Date:  2020-09       Impact factor: 1.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.